International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)-Reference-Cited by-同舟云学术

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Published:2019-01 Issue:1 Volume:39 Page:10-39
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Tsuji Brian T.¹^ORCID,Pogue Jason M.²,Zavascki Alexandre P.³⁴,Paul Mical⁵⁶,Daikos George L.⁷,Forrest Alan⁸,Giacobbe Daniele R.⁹¹⁰,Viscoli Claudio⁹¹⁰,Giamarellou Helen¹¹,Karaiskos Ilias¹¹,Kaye Donald¹²,Mouton Johan W.¹³,Tam Vincent H.¹⁴,Thamlikitkul Visanu¹⁵,Wunderink Richard G.¹⁶,Li Jian¹⁷^ORCID,Nation Roger L.¹⁸^ORCID,Kaye Keith S.¹⁹^ORCID

Affiliation:

1. School of Pharmacy and Pharmaceutical Sciences University at Buffalo State University of New York Buffalo New York

2. Detroit Medical Center Detroit Michigan

3. Department of Internal Medicine Medical School Universidade Federal, do Rio Grande do Sul Porto Alegre Brazil

4. Infectious Diseases Service Hospital de Clínicas de Porto Alegre Porto Alegre Brazil

5. Infectious Diseases Institute Rambam Health Care Campus Haifa Israel

6. The Ruth and Bruce Rappaport Faculty of Medicine Technion Israel Institute of Technology Haifa Israel

7. First Department of Propaedeutic Medicine Laikon Hospital Medical School National and Kapodistrian University of Athens Athens Greece

8. Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina

9. Infectious Diseases Unit Ospedale Policlinico San Martino–Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia Genoa Italy

10. Department of Health Sciences University of Genoa Genoa Italy

11. 1st Department of Internal Medicine, Infectious Diseases Hygeia General Hospital Athens Greece

12. Drexel University College of Medicine Philadelphia Pennsylvania

13. Department of Medical Microbiology and Infectious Diseases Erasmus MC Rotterdam The Netherlands

14. University of Houston College of Pharmacy Houston Texas

15. Division of Infectious Diseases and Tropical Medicine Department of Medicine Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

16. Division of Pulmonary and Critical Care Department of Medicine Northwestern University Feinberg School of Medicine Chicago Illinois

17. Department of Microbiology Monash Biomedicine Discovery Institute Monash University Clayton Victoria Australia

18. Drug Delivery, Disposition and Dynamics Monash Institute of Pharmaceutical Sciences Monash University Parkville Victoria Australia

19. Division of Infectious Diseases University of Michigan Medical School Ann Arbor Michigan

Funder

American College of Clinical Pharmacy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2209

Reference176 articles.

1. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

2. Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing

3. The Urgent Need for Clear and Accurate Information on the Polymyxins

4. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

5. Critical Need for Clarity in Polymyxin B Dosing

Cited by 535 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework;The Lancet Infectious Diseases;2024-02

2. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin;International Journal of Antimicrobial Agents;2024-02

3. Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections;Frontiers in Pharmacology;2024-02-01

4. Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-01-25

5. Antimicrobial resistance crisis: could artificial intelligence be the solution?;Military Medical Research;2024-01-23